Back to search results

Study of Prebiotic and Probiotic Supplement for Vaginal and Yeast Infections

This study is looking into whether a combination of a prebiotic and probiotic supplement can help relieve symptoms of bacterial vaginosis (an imbalance of bacteria in the vagina) and yeast infections. You may be able to join if you are a woman aged 25 or older, have concerns about symptoms like itching, redness, unusual discharge, or odor, and also experience digestive issues. Participants will take one of three dietary supplements daily for 30 days: the Prebiotic + Probiotic Supplement, an Active Placebo Supplement (with probiotics but no prebiotics), or an Excipient Placebo Supplement (no active ingredients). The study will measure changes in your vaginal microbiome (the community of microorganisms in your vagina) to see if the supplements are effective. The current recruitment status is unclear.

Study design
This is a virtual randomized controlled trial with 120 planned participants. Participants will be assigned by chance to one of three groups: the test product, an active placebo, or an excipient placebo.
What's involved
You would take two capsules daily with food for 30 days. Your vaginal microbiome will be measured at the start and end of the study.
Compensation
Not stated in the trial record.
Follow-up
Your vaginal microbiome will be measured at Day 30, which is the end of the treatment period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06665126

A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.

Completed
NAAges 25+InterventionalTreatment
Happy V
~120 participants
Updated 2026-08-13 on ClinicalTrials.gov
What's tested:Prebiotic + Probiotic SupplementActive Placebo SupplementExcipient Placebo Supplement

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Vaginal Microbiome
Measured over Baseline, Day 30

Conditions

Bacterial Vaginosis
Yeast Infection

Explore related trials

Bacterial VaginosisYeast Infections

NCT06665126

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Citruslabs

    Santa Monica, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women
Age 25+
Self-reported concerns symptoms associated with bacterial vaginosis or candida overgrowth, including itchiness, redness, abnormal discharge, and an unpleasant odor.
Suffers from digestive issues, including bloating, gas, or other digestive discomfort.
Generally healthy - do not live with any uncontrolled chronic diseases.
Willing to avoid using any vaginal health-related medications, supplements, and herbal remedies for the duration of this study.
If taking oral supplements or herbal remedies targeted at vaginal health, has been consistently taking these for at least 3 months prior to starting the study and is willing to maintain this routine for the study duration.

Exclusion

Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
Planning to undergo any procedure related to their vaginal health.
Started any new medications or supplements that target vaginal health in the past 3 months.
Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients
Women who are pregnant, breastfeeding, or attempting to conceive
Unwilling to follow the study protocol
Anyone who has undergone any surgeries or invasive treatments in the last three months or has any planned during the study period.

What this trial measures

  • Change in Vaginal MicrobiomeBaseline, Day 30

    This outcome measures the change in vaginal microbiome parameters from Baseline to Day 30. The vaginal microbiome will be assessed using microbiome sequencing at both Baseline and Day 30.